1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	466_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	466_QUEST_clinical_caseMIR	SENT1	-	-
3	35	35		-	-	9-11	466_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	466_QUEST_clinical_caseMIR	SENT1	-	-
5	,	,	Fc	-	-	16-17	466_QUEST_clinical_caseMIR	SENT1	-	-
6	que	que	PR0CN000	-	-	18-21	466_QUEST_clinical_caseMIR	SENT1	-	-
7	toma	tomar	VMIP3S0	C1515187	calificador	22-26	466_QUEST_clinical_caseMIR	SENT1	-	-
8	anticonceptivos	anticonceptivo	NCMP000	-	-	27-42	466_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
9	,	,	Fc	-	-	42-43	466_QUEST_clinical_caseMIR	SENT1	-	-
10	acude	acudir	VMIP3S0	-	-	44-49	466_QUEST_clinical_caseMIR	SENT1	-	-
11	a	a	SPS00	-	-	50-51	466_QUEST_clinical_caseMIR	SENT1	-	-
12	urgencias	urgencia	NCFP000	C0439609	calificador	52-61	466_QUEST_clinical_caseMIR	SENT1	-	-
13	con	con	SPS00	C0332287	atributo	62-65	466_QUEST_clinical_caseMIR	SENT1	-	-
14	síndrome	síndrome	NCMS000	C0012634#C0039082	trastorno	66-74	466_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
15	febril	febril	NC00SC0	C0015967	hallazgo	75-81	466_QUEST_clinical_caseMIR	SENT1	I-Grp_Enfermedad	-
16	y	y	CC	C1706368	calificador	82-83	466_QUEST_clinical_caseMIR	SENT1	-	-
17	parestesias	parestesia	NCFP000	C0030554	hallazgo	84-95	466_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
18	en	en	SPS00	C1720294#C0332285	calificador#atributo	96-98	466_QUEST_clinical_caseMIR	SENT1	-	-
19	hemicuerpo	hemicuerpo	NC00SC0	C0229965	estructura_corporal	99-109	466_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
20	izquierdo	izquierdo	AQ0MS0	C0205091	calificador	110-119	466_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
21	.	.	Fp	-	-	119-120	466_QUEST_clinical_caseMIR	SENT1	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	121-123	466_QUEST_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	124-126	466_QUEST_clinical_caseMIR	SENT2	-	-
3	analítica	analítica	NCFS000	-	-	127-136	466_QUEST_clinical_caseMIR	SENT2	-	-
4	de	de	SPS00	C0332285	atributo	137-139	466_QUEST_clinical_caseMIR	SENT2	-	-
5	sangre	sangre	NCFS000	C0005767	sustancia	140-146	466_QUEST_clinical_caseMIR	SENT2	-	-
6	se	se	P00CN000	-	-	147-149	466_QUEST_clinical_caseMIR	SENT2	-	-
7	observa	observar	VMIP3S0	-	-	150-157	466_QUEST_clinical_caseMIR	SENT2	-	-
8	Hb	hb	NC00YL0	-	-	158-160	466_QUEST_clinical_caseMIR	SENT2	-	-
9	7,5	7.5	Z	-	-	161-164	466_QUEST_clinical_caseMIR	SENT2	-	-
10	g	g	NCMN000	-	-	165-166	466_QUEST_clinical_caseMIR	SENT2	-	-
11	/	/	Fh	-	-	166-167	466_QUEST_clinical_caseMIR	SENT2	-	-
12	dl	decilitro	NCMN000	C0439241	calificador	167-169	466_QUEST_clinical_caseMIR	SENT2	-	-
13	,	,	Fc	-	-	169-170	466_QUEST_clinical_caseMIR	SENT2	-	-
14	plaquetas	plaqueta	NCFP000	C0005821	estructura_corporal	171-180	466_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
15	7.000/microl	7.000/microl		-	-	181-193	466_QUEST_clinical_caseMIR	SENT2	-	-
16	,	,	Fc	-	-	193-194	466_QUEST_clinical_caseMIR	SENT2	-	-
17	leucocitos	leucocito	NCMP000	C0023516	célula	195-205	466_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
18	normales	normal	AQ0CP0	C0205307	calificador	206-214	466_QUEST_clinical_caseMIR	SENT2	-	-
19	con	con	SPS00	C0332287	atributo	215-218	466_QUEST_clinical_caseMIR	SENT2	-	-
20	recuento	recuento	NCMS000	-	-	219-227	466_QUEST_clinical_caseMIR	SENT2	-	-
21	diferencial	diferencial	AQ0CS0	C0443199	calificador	228-239	466_QUEST_clinical_caseMIR	SENT2	-	-
22	normal	normal	AQ0CS0	C0205307	calificador	240-246	466_QUEST_clinical_caseMIR	SENT2	-	-
23	,	,	Fc	-	-	246-247	466_QUEST_clinical_caseMIR	SENT2	-	-
24	LDH	ldh	NC00SC0	C0022917	sustancia	248-251	466_QUEST_clinical_caseMIR	SENT2	-	-
25	1.200	1.200		-	-	252-257	466_QUEST_clinical_caseMIR	SENT2	-	-
26	UI	ui	NC00SC0	C0439453	calificador	258-260	466_QUEST_clinical_caseMIR	SENT2	-	-
27	/	/	Fh	-	-	260-261	466_QUEST_clinical_caseMIR	SENT2	-	-
28	l	l	NCFS000	-	-	261-262	466_QUEST_clinical_caseMIR	SENT2	-	-
29	,	,	Fc	-	-	262-263	466_QUEST_clinical_caseMIR	SENT2	-	-
30	reticulocitos	reticulocito	NCMP000	C0035286	célula	264-277	466_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
31	10	10	Z	-	-	278-280	466_QUEST_clinical_caseMIR	SENT2	-	-
32	%	%	Ft	-	-	281-282	466_QUEST_clinical_caseMIR	SENT2	-	-
33	(	(	Fpa	-	-	283-284	466_QUEST_clinical_caseMIR	SENT2	-	-
34	normal	normal	AQ0CS0	C0205307	calificador	284-290	466_QUEST_clinical_caseMIR	SENT2	-	-
35	0,5-2	0,5-2	Z	-	-	291-296	466_QUEST_clinical_caseMIR	SENT2	-	-
36	%	%	Ft	-	-	297-298	466_QUEST_clinical_caseMIR	SENT2	-	-
37	)	)	Fpt	-	-	298-299	466_QUEST_clinical_caseMIR	SENT2	-	-
38	,	,	Fc	-	-	299-300	466_QUEST_clinical_caseMIR	SENT2	-	-
39	haptoglobina	haptoglobina	NCFS000	C0018595	sustancia	301-313	466_QUEST_clinical_caseMIR	SENT2	-	-
40	en	en	SPS00	C1720294#C0332285	calificador#atributo	314-316	466_QUEST_clinical_caseMIR	SENT2	-	-
41	suero	suero	NCMS000	C0229671#C0588987	sustancia#producto	317-322	466_QUEST_clinical_caseMIR	SENT2	-	-
42	indetectable	indetectable	AQ0CS0	-	-	323-335	466_QUEST_clinical_caseMIR	SENT2	-	-
43	,	,	Fc	-	-	335-336	466_QUEST_clinical_caseMIR	SENT2	-	-
44	test	test	NCMS000	-	-	337-341	466_QUEST_clinical_caseMIR	SENT2	-	-
45	de	de	SPS00	C0332285	atributo	342-344	466_QUEST_clinical_caseMIR	SENT2	-	-
46	Coombs	coombs	NCMP000	-	-	345-351	466_QUEST_clinical_caseMIR	SENT2	-	-
47	directo	directo	AQ0MS0	C0439851	calificador	352-359	466_QUEST_clinical_caseMIR	SENT2	-	-
48	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	360-368	466_QUEST_clinical_caseMIR	SENT2	-	-
49	y	y	CC	C1706368	calificador	369-370	466_QUEST_clinical_caseMIR	SENT2	-	-
50	frotis	frotis	NCMN000	-	-	371-377	466_QUEST_clinical_caseMIR	SENT2	-	-
51	de	de	SPS00	C0332285	atributo	378-380	466_QUEST_clinical_caseMIR	SENT2	-	-
52	sangre	sangre	NCFS000	C0229664_1	sustancia_1	381-387	466_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
53	periférica	periférico	AQ0FS0	C0229664_2	sustancia_2	388-398	466_QUEST_clinical_caseMIR	SENT2	I-Estructura_Corporal	-
54	con	con	SPS00	C0332287	atributo	399-402	466_QUEST_clinical_caseMIR	SENT2	-	-
55	esquistocitos	esquistocito	NCMP000	C0221282	célula	403-416	466_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
56	.	.	Fp	-	-	416-417	466_QUEST_clinical_caseMIR	SENT2	-	-

1	Coagulación	coagulación	NCFS000	C0441509	procedimiento	418-429	466_QUEST_clinical_caseMIR	SENT3	-	-
2	(	(	Fpa	-	-	430-431	466_QUEST_clinical_caseMIR	SENT3	-	-
3	tiempo	tiempo	NCMS000	C0033707_1	procedimiento_1	431-437	466_QUEST_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0033707_2	procedimiento_2	438-440	466_QUEST_clinical_caseMIR	SENT3	-	-
5	protrombina	protrombina	NCFS000	C0033707_3	procedimiento_3	441-452	466_QUEST_clinical_caseMIR	SENT3	-	-
6	y	y	CC	C1706368	calificador	453-454	466_QUEST_clinical_caseMIR	SENT3	-	-
7	APTT	activated_partial_thromboplastin_time_(tiempo_de_tromboplastina_parcial_activada)	NC00YL0	-	-	455-459	466_QUEST_clinical_caseMIR	SENT3	-	-
8	)	)	Fpt	-	-	459-460	466_QUEST_clinical_caseMIR	SENT3	-	-
9	normal	normal	AQ0CS0	C0205307	calificador	461-467	466_QUEST_clinical_caseMIR	SENT3	-	-
10	.	.	Fp	-	-	467-468	466_QUEST_clinical_caseMIR	SENT3	-	-

1	¿	¿	Fia	-	-	469-470	466_QUEST_clinical_caseMIR	SENT4	-	-
2	Cuál	cuál	PT0CS000	-	-	470-474	466_QUEST_clinical_caseMIR	SENT4	-	-
3	de	de	SPS00	C0332285	atributo	475-477	466_QUEST_clinical_caseMIR	SENT4	-	-
4	los	el	DA0MP0	-	-	478-481	466_QUEST_clinical_caseMIR	SENT4	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	482-492	466_QUEST_clinical_caseMIR	SENT4	-	-
6	es	ser	VSIP3S0	-	-	493-495	466_QUEST_clinical_caseMIR	SENT4	-	-
7	el	el	DA0MS0	-	-	496-498	466_QUEST_clinical_caseMIR	SENT4	-	-
8	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	499-510	466_QUEST_clinical_caseMIR	SENT4	-	-
9	más	más	RG	C0205172	calificador	511-514	466_QUEST_clinical_caseMIR	SENT4	-	-
10	probable	probable	AQ0CS0	C0332148	calificador	515-523	466_QUEST_clinical_caseMIR	SENT4	-	-
11	?	?	Fit	-	-	523-524	466_QUEST_clinical_caseMIR	SENT4	-	-
12	:	:	Fd	-	-	524-525	466_QUEST_clinical_caseMIR	SENT4	-	-
13	.	.	Fp	-	-	525-526	466_QUEST_clinical_caseMIR	SENT4	-	-

